Name: Return on Equity (ROE)

Definition: ROE shows how much profit the company earns for its shareholders based on their invested equity. It’s one of the most watched profitability ratios. A consistently high ROE signals strong management and efficient use of shareholder capital. But artificially high ROE may sometimes be boosted by excessive debt.

Interpretation:
• In '2022', DHAI's return on equity was 3.3%, measuring profitability for shareholders. Industry average for Medical/Dental Instruments in '2022' stood at -44.7%.
• In '2022', DHAI's return on equity was 3.3%, measuring profitability for shareholders. The figure remained stable compared to '2022'. Industry average for Medical/Dental Instruments in '2022' stood at -44.7%. Industry average remained unchanged from prior year.
• In '2023', DHAI's return on equity was 0.5%, measuring profitability for shareholders. The decline from '2022' may indicate some operational or financial challenges. Industry average for Medical/Dental Instruments in '2023' stood at -74.1%. Industry average declined by 29.3% from previous year.
• In '2023', DHAI's return on equity was 0.5%, measuring profitability for shareholders. The figure remained stable compared to '2023'. Industry average for Medical/Dental Instruments in '2023' stood at -74.1%. Industry average remained unchanged from prior year.
• In '2024', DHAI's return on equity was -119.3%, measuring profitability for shareholders. The decline from '2023' may indicate some operational or financial challenges. Industry average for Medical/Dental Instruments in '2024' stood at -45.9%. Industry average increased by 28.1% compared to previous year.
Overall, DHAI's return on equity has been volatile but showed a downward trend over the past 5 years.

Formula: ROE = Net Income / Shareholders' Equity

Good Range: 10%-20% desirable for many industries.